Arriello appoints experienced biotech expert, Kate Coleman as VP of Quality & Compliance.
Industrial microbiology and quality risk management specialist Kate Coleman will join Arriello in September as VP of Quality & Compliance.
RAPS Euro Convergence 2023
We are pleased to announce we will be in Amsterdam, The Netherlands, for the RAPS Euro Convergence 2023 from 10 to 12 May.
Sonia Mangnoesing appointed as Director of Drug Safety.
Sonia has 20 years of experience in global and local pharmacovigilance in both large pharma and service provider organizations.
Arriello speaking at the CMO 360 Summit, Boston.
Our Chief Regulatory Officer Peter Embley will be speaking at the biotech focused Chief Medical Officer Summit 360 event in Boston April 3-4.
Sam Tomlinson appointed as VP of Global Drug Safety.
Sam has over 20 years strategic and operational experience and will develop and direct our clinical and non-clinical pharmacovigilance services and solutions.
Arriello Conference Prague 2023
Arriello’s first all-staff conference in Prague focused on the entire customer journey, from acquisition to potential advocacy.
Arriello Conference, Prague January 2023.
Bringing teams from all locations together for a day and a half, the conference theme focused on the entire customer journey.
J.P. Morgan 41st Annual Healthcare Conference
We are pleased to announce we will be in San Francisco for the 41st J.P. Morgan Healthcare Conference from the 9th to the 12th of January, and additionally on the 13th.
Arriello’s new office in San Francisco, USA.
We have opened a new West Coast office location right in the heart of Biotech Bay, South San Francisco at 611 Gateway Blvd, Suite 120.
Why choose Arriello by Kieran O’Donnell
In this video, Arriello’s VP of Global Drug Safety Kieran O’Donnell talks about why Arriello is unique in the industry in offering strategic consulting alongside a range of expert drug safety services.
